<DOC>
	<DOCNO>NCT00648453</DOCNO>
	<brief_summary>To determine whether laser Doppler flowmetric parameter characteristic endothelial dysfunction patient clinically manifest atherosclerosis change detect plavix ( clopidogrel ) treatment . Laser Doppler /LD/ measurement combine iontophoresis evaluates effect acetylcholine /ACh/ /endothelium dependent/ sodium nitroprusside /NSP/ /endothelium independent/ microcirculation skin</brief_summary>
	<brief_title>Effect Plavix NO ( Nitrogen Monoxide ) Production Endothelial Function</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Proven , peripheral arterial disease , Fontain IIIII stage , patient submit secondary prophylactic thrombocyte aggregation inhibit treatment Doppler index &lt; 0,8 Hypersensitivity active ingredient one component drug Active pathological bleeding , e.g . gastric ulcer , intracranial bleeding Pregnancy , breastfeed Severe , know hepatic insufficiency Severe , know renal insufficiency The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Fontain II-III stage</keyword>
</DOC>